HomeSearch by MicroorganismStaphylococcus intermedius (coagulase-negative + oxacillin-susceptible)
Microorganism
MIC50
(μg/ml)
sort
MIC90
(μg/ml)
sort
Range
(μg/ml)
sort
Antimicrobial sort
Reference
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 0.12 0.25 ≤0.06 - >8 Clindamycin (Cleocin) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 0.12 2 ≤0.03 - >4 Gatifloxacin (Tequin) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) >0.25 >2 0.06 - >2 Ciprofloxacin (Cipro, Ciproxin, Ciprobay) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) ≤0.5 ≤0.5 ≤0.5 - >8 Imipenem 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 0.5 1 ≤0.5 - 8 Zosyn 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 0.5 2 ≤0.12 - 8 Cefepime (Maxipime) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) >0.5 >2 ≤0.5 - >2 Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 1 2 ≤0.12 - 4 Vancomycin (Vancocyn, Lyphocin) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 2 4 ≤0.25 - >32 Ceftriaxone (Rocephin) 412
Staphylococcus intermedius (coagulase-negative + oxacillin-susceptible) 4 8 0.25 - >16 Ceftazidime (Ceptaz, Fortaz, Tanicef) 412